Gyre TherapeuticsGYRE
那斯達克 · USD
6.65
-0.03
(-0.45%)
收盤 08/27 03:54 (UTC+8)
08/27 03:54 (UTC+8)
Gyre TherapeuticsGYRE
6.65
-0.03
(-0.45%)
財務數據
損益表
- 0.27
- 0.25
- 0.25
- 0.28
- 0.22
- 0.27
- 0.19
- 0.37
- 0.23
- 0.31
- -76.05
- -7.17
- 1.04
- 9.35
- -20.86
- 21.37
- -28.70
- 21.70
- -39.46
- 37.73
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 31,016 | 22,519 | 37,195 | 19,088 | 26,771 | 22,058 | 27,872 | 25,488 | 25,225 | 27,172 |
營業成本 | 2,209 | 1,227 | 1,743 | 1,628 | 1,151 | 894 | 1,177 | 958 | 770 | 979 |
營業毛利 | 28,807 | 21,292 | 35,452 | 17,460 | 25,620 | 21,164 | 26,695 | 24,530 | 24,455 | 26,193 |
營業費用 | 52,789 | 30,647 | 35,332 | 6,391 | 23,448 | 18,891 | 26,032 | 20,297 | 21,193 | 18,122 |
研發費用 | 23,879 | 6,738 | 4,815 | -7,559 | 3,425 | 3,095 | 3,712 | 2,775 | 3,355 | 2,182 |
推銷及管理費用 | 28,910 | 23,909 | 30,517 | 13,950 | 20,023 | 15,796 | 22,320 | 17,522 | 17,838 | 15,940 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -23,982 | -9,355 | 118 | 11,067 | 2,171 | 2,273 | 665 | 4,233 | 3,262 | 8,071 |
其他收入及費用 | 755 | 118 | -186 | -832 | 66 | 2,362 | 109 | -303 | 2,773 | 4,410 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,227 | -9,237 | -66 | 10,237 | 2,238 | 4,635 | 772 | 3,930 | 6,035 | 12,481 |
所得稅 | -236 | 621 | 1,300 | 1,693 | 662 | 901 | 203 | 1,074 | 1,497 | 2,546 |
稅後純益 | -12,213 | -8,691 | -1,723 | 1,404 | 442 | 2,698 | -99 | 1,124 | 3,528 | 7,532 |
基本每股稅後盈餘(元) | -0.12 | -0.10 | -0.02 | 0.04 | - | 0.03 | - | 0.01 | 0.04 | 0.09 |
稀釋每股稅後盈餘(元) | -0.16 | -0.10 | -0.02 | 0.07 | -0.03 | - | - | 0.01 | 0.01 | 0.03 |
基本平均股數(千股) | 100637.00 | 91317.00 | 91156.00 | 90850.00 | 89119.00 | 86420.00 | 85952.00 | 85643.00 | 85502.00 | 83265.00 |
稀釋平均股數(千股) | 100637.00 | 91344.00 | 91156.00 | 103971.00 | 102701.00 | 101970.00 | 85952.00 | 102640.00 | 104325.00 | 102594.00 |
還原基本每股稅後盈餘(元) | -0.12 | -0.10 | -0.02 | 0.04 | - | 0.03 | - | 0.01 | 0.04 | 0.09 |
還原稀釋每股稅後盈餘(元) | -0.16 | -0.10 | -0.02 | 0.07 | -0.03 | - | - | 0.01 | 0.01 | 0.03 |
還原基本平均股數(千股) | 100,637 | 91,317 | 91,156 | 90,850 | 89,119 | 86,420 | 85,952 | 85,643 | 85,502 | 83,265 |
還原稀釋平均股數(千股) | 100,637 | 91,344 | 91,156 | 103,971 | 102,701 | 101,970 | 85,952 | 102,640 | 104,325 | 102,594 |
EBITDA(千元) | -10,976 | -7,398 | 272 | 3,422 | 1,745 | 4,134 | 604 | 2,652 | 5,273 | 10,503 |